EDRH
PACB icon

Edmond de Rothschild Holding’s Pacific Biosciences PACB Stock Holding History

Edmond de Rothschild Holding’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,675,200
Closed -$13.7M – 597
2025
Q3 		$13.7M Sell
10,675,200
-2,691,000
-20% -$3.64M 0.21% 102
2025
Q2 		$16.6M Sell
13,366,200
-8,488,980
-39% -$9.8M 0.26% 93
2025
Q1 		$25.8M Buy
21,855,180
+508,700
+2% +$780K 0.46% 60
2024
Q4 		$39.1M Buy
21,346,480
+1,038,600
+5% +$2.03M 0.67% 35
2024
Q3 		$34.5M Buy
20,307,880
+3,571,460
+21% +$5.87M 0.56% 45
2024
Q2 		$22.9M Buy
16,736,420
+6,229,133
+59% +$12.6M 0.39% 66
2024
Q1 		$39.4M Buy
10,507,287
+9,511,787
+955% +$55.7M 0.66% 42
2023
Q4 		$9.77M Buy
995,500
+188,600
+23% +$1.54M 0.17% 131
2023
Q3 		$6.74M Buy
806,900
+379,400
+89% +$4.34M 0.14% 141
2023
Q2 		$5.69M Buy
+427,500
New +$5.2M 0.11% 162
2017
Q2 		– Sell
-1,100
Closed -$6K – 845
2017
Q1 		$6K Buy
+1,100
New +$5.38K ﹤0.01% 787
2016
Q4 		– Sell
-5,560
Closed -$50K – 867
2016
Q3 		$50K Buy
+5,560
New +$46.5K ﹤0.01% 665
2015
Q4 		– Sell
-12,000
Closed -$44K – 866
2015
Q3 		$44K Sell
12,000
-14,000
-54% -$68.4K ﹤0.01% 639
2015
Q2 		$150K Buy
+26,000
New +$150K ﹤0.01% 519

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Edmond de Rothschild Holding's PACB Position: Q4 2025 in Review

Edmond de Rothschild Holding sold out of Pacific Biosciences (PACB) in Q4 2025, closing a stake of 10,675,200 shares — an estimated $13.7M sold.

Edmond de Rothschild Holding first reported a position in PACB in Q2 2015 and held it in 14 quarters. The position peaked at $39.4M in Q1 2024. 215 funds tracked by Wall St. Rank hold PACB as of Q4 2025.

  • Edmond de Rothschild Holding reported no remaining Pacific Biosciences position as of Q4 2025 after selling out during the quarter.
  • Edmond de Rothschild Holding sold 10,675,200 Pacific Biosciences shares in Q4 2025, an estimated $13.7M.
  • Edmond de Rothschild Holding first reported a position in Pacific Biosciences in Q2 2015 and held it in 14 quarters.
  • Edmond de Rothschild Holding's Pacific Biosciences position peaked at $39.4M in Q1 2024.
  • 215 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2025.

Based on Edmond de Rothschild Holding's 13F filing for Q4 2025, filed 17 Feb 2026.